Exact Sciences (EXAS) Thoughts After Post-Earnings NDR - Stifel
Tweet Send to a Friend
Stifel analyst Daniel Arias reiterated a Buy rating and $110.00 price target on Exact Sciences (NASDAQ: EXAS) after hosting investor ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


